Federal Register / Vol. 62, No. 250 / Wednesday, December 31, 1997 / Notices 68295

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

Citizens Advisory Committee on Public

Health Service Activities and Research

at Department of Energy (DOE) Sites:

Hanford Health Effects Subcommittee

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Agency for Toxic

Substances and Disease Registry

(ATSDR) and the Centers for Disease

Control and Prevention (CDC) announce

the following meeting.

Name: Citizens Advisory Committee on

Public Health Service Activities and

Research at DOE Sites: Hanford Health

Effects Subcommittee (HHES).

Times and Dates: 9 a.m.–5 p.m., January

15, 1998; 6:30 p.m.–8:30 p.m., January 15,

1998; 8 a.m.–3 p.m., January 16, 1998.

Place: Doubletree Hotel/Jantzen Beach, 909

North Hayden Island Drive, Portland, Oregon

97217, telephone 503/283–4466, fax 503/

283–4743.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 150 people.

Background: A Memorandum of

Understanding (MOU) was signed in October

1990 and renewed in November 1992

between ATSDR and DOE. The MOU

delineates the responsibilities and

procedures for ATSDR’s public health

activities at DOE sites required under

sections 104, 105, 107, and 120 of the

Comprehensive Environmental Response,

Compensation, and Liability Act (CERCLA or

‘‘Superfund’’). These activities include health

consultations and public health assessments

at DOE sites listed on, or proposed for, the

Superfund National Priorities List and at

sites that are the subject of petitions from the

public; and other health-related activities

such as epidemiologic studies, health

surveillance, exposure and disease registries,

health education, substance-specific applied

research, emergency response, and

preparation of toxicological profiles.

In addition, under an MOU signed in

December 1990 with DOE and replaced by an

MOU signed in 1996, the Department of

Health and Human Services (HHS) has been

given the responsibility and resources for

conducting analytic epidemiologic

investigations of residents of communities in

the vicinity of DOE facilities, workers at DOE

facilities, and other persons potentially

exposed to radiation or to potential hazards

from non-nuclear energy production and use.

HHS has delegated program responsibility to

CDC.

Purpose: This subcommittee is charged

with providing advice and recommendations

to the Director, CDC, and the Administrator,

ATSDR, regarding community, American

Indian tribes, and labor concerns pertaining

to CDC’s and ATSDR’s public health

activities and research at this DOE site.

Activities shall focus on providing a forum

for community, American Indian Tribal, and

labor interaction and serve as a vehicle for

community concern to be expressed as

advice and recommendations to CDC and

ATSDR.

Matters To Be Discussed: Agenda items

include: ATSDR’s proposed medical

monitoring program, ATSDR’s planning for

an exposure subregistry program, and

solicitations of subcommittee concerns to be

addressed by ATSDR and CDC. There will

also be updates from the Inter-tribal Council

on Hanford Health Projects, and reports from

the following Work Groups: Outreach/

Special Populations, Public Health Activities,

and Health Studies.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information: Jim

Carpenter, Public Health Advisor, ATSDR, E–

32, 1600 Clifton Road, NE, Atlanta, Georgia

30333, telephone 404/639–6027, fax 404/

639–4699.

Dated: December 19, 1997.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 97–34045 Filed 12–30–97; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Advisory Committee Meeting;

Amendment of Notice

AGENCY: Food and Drug

Administration, HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

amendment to the notice of meeting of

the Orthopaedic and Rehabilitation

Devices Panel of the Medical Devices

Advisory Committee. This meeting was

announced in the Federal Register of

December 15, 1997. The amendment is

being made to reflect a change in the

agenda and procedure which will

change the order of reclassification

petitions being presented to the

committee and will also change the

order of the open public hearings

associated with each petition. There are

no other changes. This amendment will

be announced at the beginning of the

open portion of the meeting.

FOR FURTHER INFORMATION CONTACT: Jodi

H. Nashman, Center for Devices and

Radiological Health (HFZ–410), Food

and Drug Administration, 9200

Corporate Blvd., Rockville, MD 20850,

301–594–2036, or FDA Advisory

Committee Information Line, 1–800–

741–8138 (301–443–5072 in the

Washington, DC area), code 12521.

Please call the Information Line for upto-date information on this meeting.

SUPPLEMENTARY INFORMATION: In the

Federal Register of December 15, 1997

(62 FR 65709), FDA announced that a

meeting of the Orthopaedic and

Rehabilitation Devices Panel of the

Medical Devices Advisory Committee

would be held on January 12 and 13,

1998. On page 65709, beginning in the

3d column, the Agenda and Procedure

portions are amended to read as follows:

Agenda: On January 12, 1998, the

committee will discuss and make

recommendations for reclassification

petitions for non- and semi-constrained

shoulders and constrained elbows. On

January 13, 1998, the committee will

discuss and make recommendations for

reclassification petitions for

patellofemoral knees and uni- and total

patellofemorotibial knees, and for

classification of calcium sulfate preformed pellets (plaster of paris pellets).

Procedure: Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by January 5, 1998. Oral

presentations from the public regarding

reclassification petitions for non- and

semi-constrained shoulders and

constrained elbows will be scheduled

between approximately 11 a.m. and 12

m. on January 12, 1998. Oral

presentations from the public regarding

reclassification petitions for

patellofemoral knees and uni- and total

patellofemorotibial knees, as well as for

classification of calcium sulfate preformed pellets (plaster of paris pellets)

will be scheduled between

approximately 7:30 a.m. and 8:30 a.m.

on January 13, 1998. Time allotted for

each presentation may be limited. Those

desiring to make formal oral

presentations should notify the contact

person by January 5, 1998, and submit

a brief statement of the general nature of

the evidence or arguments they wish to

present, the names and addresses of

proposed participants, and an

indication of the approximate time

requested to make their presentation.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: December 24, 1997.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 97–34058 Filed 12-24-97; 10:56 am]

BILLING CODE 4160–01–F